The effect of oxandrolone on body proportions and body composition in growth hormone-treated girls with Turner syndrome

被引:12
|
作者
Menke, Leonie A. [1 ,2 ]
Sas, Theo C. J. [1 ,3 ,4 ]
Zandwijken, Gladys R. J. [2 ]
de Ridder, Maria A. J. [5 ]
Stijnen, Theo [6 ]
Keizer-Schrama, Sabine M. P. F. de Muinck [3 ]
Otten, Barto J. [7 ]
Wit, Jan M. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Paediat, NL-2300 RC Leiden, Netherlands
[2] Dutch Growth Res Fdn, Rotterdam, Netherlands
[3] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Paediat, Rotterdam, Netherlands
[4] Albert Schweitzer Hosp, Dept Paediat, Dordrecht, Netherlands
[5] Erasmus MC, Dept Biostat, Rotterdam, Netherlands
[6] Leiden Univ, Med Ctr, Dept Biostat, NL-2300 RC Leiden, Netherlands
[7] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
关键词
AGE REFERENCES; SHORT STATURE; MUSCLE MASS; CHILDREN; HEIGHT; RATIO; FAT;
D O I
10.1111/j.1365-2265.2010.03789.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P>Objective Untreated girls with Turner syndrome (TS) have short stature, relatively broad shoulders, a broad pelvis, short legs, a high fat mass and low muscle mass. Our objective was to assess the effect of the weak androgen oxandrolone (Ox) on body proportions and composition in growth hormone (GH)-treated girls with TS. Design/Patients 133 patients were included in a randomized, placebo-controlled, double-blind study. Methods Patients were treated with GH (1 center dot 33 mg/m2 per day) from baseline, combined with placebo (Pl) or Ox in a low (0 center dot 03 mg/kg per day) or previously conventional (0 center dot 06 mg/kg per day) dose from the age of eight, and oestrogens from the age of twelve. Sitting height, biacromial and biiliacal distances compared with height (i.e. shape values), BMI, waist circumference, sum of 4 skinfolds (sum4skin) and upper arm muscle area (UAMA) SD scores (SDS) were assessed half-yearly. Results Compared with GH + Pl, adult shape values on GH + Ox tended to be higher for sitting height (Ox 0 center dot 03, P = 0 center dot 2; Ox 0 center dot 06, P = 0 center dot 02) and biacromial distance (Ox 0 center dot 03, P = 0 center dot 2; Ox 0 center dot 06, P = 0 center dot 07) and lower for biiliacal distance (Ox 0 center dot 03, P = 0 center dot 004; Ox 0 center dot 06, P = 0 center dot 08). Sum4skin SDS tended to decrease more (Ox 0 center dot 03, P = 0 center dot 2; Ox 0 center dot 06, P = 0 center dot 005) while UAMA SDS increased more (Ox 0 center dot 03, P < 0 center dot 001; Ox 0 center dot 06, P < 0 center dot 001) than on GH + Pl. The increase in BMI and waist circumference SDS was comparable between the dosage groups. Conclusions In GH-treated girls with TS, Ox 0 center dot 06 increases sitting height and tends to increase biacromial distance and decrease biiliacal distance, while Ox 0 center dot 03 significantly decreases biiliacal distance compared with height. Furthermore, Ox 0 center dot 06 reduces subcutaneous fat mass, and both Ox dosages increase muscle mass.
引用
收藏
页码:212 / 219
页数:8
相关论文
共 50 条
  • [41] Growth charts of Brazilian girls with Turner syndrome without the use of GH or oxandrolone
    Carpini-Dantas, Stela
    Guerra-Junior, Gil
    Maciel-Guerra, Trevas
    Marmo, Denise Barbieri
    Vieira, Tarsis Paiva
    Lopes, Carolina Paniago
    Baptista, Maria Tereza Matias
    Morcillo, Andre Moreno
    de Lemos-Marini, Sofia Helena Valente
    JORNAL DE PEDIATRIA, 2025, 101 (02) : 231 - 237
  • [42] Comparison of Body Surface Area versus Weight-Based Growth Hormone Dosing for Girls with Turner Syndrome
    Schrier, Lenneke
    de Kam, Marieke L.
    McKinnon, Rachel
    Bakri, Amalina Che
    Oostdijk, Wilma
    Sas, Theo C. J.
    Menke, Leonie A.
    Otten, Barto J.
    Keizer-Schrama, Sabine M. P. F. de Muinck
    Kristrom, Berit
    Ankarberg-Lindgren, Carina
    Burggraaf, Jacobus
    Albertsson-Wikland, Kerstin
    Wit, Jan M.
    HORMONE RESEARCH IN PAEDIATRICS, 2014, 81 (05): : 319 - 330
  • [43] Long-Term Follow-Up of GH-Treated Girls with Turner Syndrome: BMI, Blood Pressure, Body Proportions
    Bannink, Ellen M. N.
    van der Palen, Roel L. F.
    Mulder, Paul G. H.
    Keizer-Schrama, Sabine M. P. F. de Muinck
    HORMONE RESEARCH, 2009, 71 (06) : 336 - 342
  • [44] Comments on 'Prospective Study Confirms Oxandrolone-Associated Improvement in Height in Growth Hormone-Treated Adolescent Girls with Turner Syndrome' by Zeger et al., pp. 39-47, this issue
    Menke, Leonie A.
    Sas, Theo C. J.
    Wit, Jan M.
    HORMONE RESEARCH IN PAEDIATRICS, 2011, 75 (01): : 47 - 48
  • [45] Growth hormone treatment regimens in girls with Turner syndrome
    Keizer-Schrama, SMPFD
    Sas, TCJ
    ACTA PAEDIATRICA, 1999, 88 : 126 - 129
  • [46] 24 HOUR GROWTH-HORMONE PROFILES IN TURNER SYNDROME AND THE EFFECTS OF OXANDROLONE
    MASSARANO, AA
    PRINGLE, PJ
    HINDMARSH, PC
    STANHOPE, R
    PREECE, MA
    BROOK, CGD
    PEDIATRIC RESEARCH, 1988, 23 (01) : 127 - 127
  • [47] Prader-Willi syndrome: The effect of growth hormone on childhood body composition
    Carrel, AL
    Myers, SE
    Whitman, BY
    Allen, DB
    ENDOCRINOLOGIST, 2000, 10 (04): : 43S - 49S
  • [48] Final height outcome in girls with Turner syndrome treated with a combination of low dose oestrogen and oxandrolone
    P. Bareille
    A. A. Massarano
    R. Stanhope
    European Journal of Pediatrics, 1997, 156 : 358 - 362
  • [49] Final height outcome in girls with Turner syndrome treated with a combination of low dose oestrogen and oxandrolone
    Bareille, P
    Massarano, AA
    Stanhope, R
    EUROPEAN JOURNAL OF PEDIATRICS, 1997, 156 (05) : 358 - 362
  • [50] CARBOHYDRATE-METABOLISM IN TURNER SYNDROME (TS) - THE EFFECT OF GROWTH-HORMONE (GH) AND OXANDROLONE (OX)
    WILSON, DM
    FRANE, JW
    SHERMAN, B
    JOHANSON, AJ
    HINTZ, RL
    ROSENFELD, RG
    PEDIATRIC RESEARCH, 1987, 21 (04) : A350 - A350